Prognostic significance of beta-catenin expression in patients with esophageal carcinoma: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 15, 2014, Pages 6103-6108

  Zeng, Rong ^a   Duan, Lei ^a   Kong, Yu Ke ^a   Wu, Xiao Lu ^a   Wang, Ya ^a   Xin, Gang ^a   Yang, Ke Hu ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Esophageal carcinoma; Meta analysis; Prognosis; catenin

Indexed keywords

BETA CATENIN; CTNNB1 PROTEIN, HUMAN; TUMOR MARKER;

CASE CONTROL STUDY; ESOPHAGUS TUMOR; HUMAN; META ANALYSIS; METABOLISM; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

BETA CATENIN; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; HUMANS; PROGNOSIS; SURVIVAL RATE;

EID: 84906256871     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.15.6103     Document Type: Article

References (44)

1. Aberle H, Schwartz H, Kemler R (1996). Cadherin-catenin complex: protein interactions and their implications for cadherin function. J Cell Biochem, 61, 514-23.
2. Barker N, Clevers H (2006). Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov, 5, 997-1014.
3. Chen W, Suo J, Shi J, et al (2011). β-catenin expression and prognosis in human esophageal squamous cell carcinoma. Zhong Hua Zhong Liu Fang Zhi Za Zhi, 18, 672-5.
4. Chen Z, He X, Jia M, et al (2013). β-catenin overexpression in the nucleus predicts progress disease and unfavourable survival in colorectal cancer: a meta-analysis. PLoS One, 8, 63854.
5. Corrigan PM, Dobbin E, Freeburn RW, et al (2009). Patterns of Wnt/Fzd/LRP gene expression during embryonic hematopoiesis. Stem Cells Dev, 18, 759-72.
6. Duan XL, Gong H, Zeng XT, et al (2012). Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: a meta-analysis. Asian Pac J Cancer Prev, 13, 3299-303.
7. Fang Y, Xiao F, An Z, et al (2011). Systematic review on the relationship between genetic polymorphisms of methylenetetrahydrofolate reductase and esophageal squamous cell carcinoma. Asian Pac J Cancer Prev, 12, 1861-6.
8. Guan CN, Chen XM, Lou HQ, et al (2012). Clinical significance of axin and β-catenin protein expression in primary hepatocellular carcinomas. Asian Pac J Cancer Prev, 13, 677-81.
9. Higgins JPT, Green S, et al (2011). Cochrane handbook for systematic reviews of interventions, version 5.1.0. Chi Chester, West Sussex: The Cochrane Collaboration and John Wiley & Sons.
10. Hirohashi S (1998). Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol, 153, 333-9.
11. Hsu PK, Li AF, Wang YC, et al (2008). Reduced membranous beta-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus. J Thorac Cardiovasc Surg, 135, 1029-35.
12. Ilyas M (2005). Wnt signalling and the mechanistic basis of tumour development. J Pathol, 205, 130-44.
13. Ilyas M, Tomlinson IP (1997). The interactions of APC, E-cadherin and beta-catenin in tumour development and progression. J Pathol, 182, 128-37.
14. Ivanov DB, Philippova MP, Tkachuk VA (2001). Structure and functions of classical cadherins. Biochemistry, 66, 1174-86.
15. Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49.
16. Krishnadath KK, Tilanus HW, van Blankenstein M, et al (1997). Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol, 182, 331-8.
17. Li AF, Hsu PK, Tzao C, et al (2009). Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus. Ann Surg Oncol, 16, 2486-93.
18. Lin CX, Wu J, Wang CH, et al (2008). E-cadherin-β-catenint complex expression and clinicopathologic properties in esophageal carcinoma patients and their relationship with the prognosis. Shi Jie Hua Ren Xiao Hua Za Zhi, 16, 3687-91.
19. Lv J, Cao XF, Ji L, et al (2012). Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma. Med Oncol, 29, 151-60.
20. Mei XD, Su H, Song J, et al (2013). Prognostic significance of β-catenin expression in patients with non-small cell lung cancer: a meta-analysis. Biosci Trends, 7, 42-9.
21. Moher D, Liberati A, TetzlaffJ, et al (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 339, 2535.
22. Montesano R, Hollstein M, Hainaut P (1996). Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer, 69, 225-35.
23. Nagano O, Saya H (2004). Mechanism and biological significance of CD44 cleavage. Cancer Sci, 95, 930-5.
24. Nelson WJ, Nusse R (2004). Convergence of Wnt, beta-catenin, and cadherin pathways. Science, 303, 1483-7.
25. Nozoe T, Oyama T, Uramoto H, et al (2009). Reduced expression of catenin subtypes is a potential indicator of unfavorable prognosis in esophageal squamous cell carcinoma. Mol Med Rep, 2, 353-7.
26. Pandurangan AK (2013). Potential targets for prevention of colorectal cancer: a focus on PI3K/Akt/mTOR and Wnt pathways. Asian Pac J Cancer Prev, 14, 2201-5.
27. Reed PI, Johnston BJ (1993). The changing incidence of oesophageal cancer. Endoscopy, 25, 606-8.
28. Saad N, Esa NM, Ithnin H (2013). Suppression of β-catenin and cyclooxygenase-2 expression and cell proliferation in azoxymethane-induced colonic cancer in rats by rice bran phytic acid (PA). Asian Pac J Cancer Prev, 14, 3093-9.
29. Shiozaki H, Doki Y, Kawanishi K, et al (2000). Clinical application of malignancy potential grading as a prognostic factor of human esophageal cancers. Surgery, 127, 552-61.
30. Situ DR, Hu Y, Zhu ZH, et al (2010). Prognostic relevance of β-catenin expression in T2-3N0M0 esophageal squamous cell carcinoma. World J Gastroenterol, 16, 5195-202.
31. Stang A (2010). Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 25, 603-5.
32. Tierney JF, Stewart LA, Ghersi D, et al (2007). Practical methods for incorporating summary time-to-event data into metaanalysis. Trials, 8, 16.
33. Wang J, Ge J, Zhang XH, et al (2014). Endoscopic submucosal dissection versus endoscopic mucosal resection for the treatment of early esophageal carcinoma: a meta-analysis. Asian Pac J Cancer Prev, 15, 1803-6.
34. Wang JS, Ji AF, Wan HJ, et al (2012). Gene silencing of β-catenin by RNAi inhibits proliferation of human esophageal cancer cells by inducing G0/G1 cell cycle arrest. Asian Pac J Cancer Prev, 13, 2527-32.
35. Wang LS, Chow KC, Chi KH, et al (1999). Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors. Am J Gastroenterol, 94, 1933-40.
36. Wang W, Xue L, Wang P (2011). Prognostic value of β-catenin, c-myc, and cyclin D1 expressions in patients with esophageal squamous cell carcinoma. Med Oncol, 28, 163-9.
37. Wen YY, Yang SJ, Zhang JX, et al (2013). Methylenetetrahydrofolate reductase genetic polymorphisms and esophageal squamous cell carcinoma susceptibility: a meta-analysis of case-control studies. Asian Pac J Cancer Prev, 14, 21-5.
38. Wijnhoven BP, Dinjens WN, Pignatelli M (2000). E-cadherincatenin cell-cell adhesion complex and human cancer. Br J Surg, 87, 992-1005.
39. Xu XH, Peng XH, Yu P, et al (2012). Neoadjuvant chemotherapy for resectable esophageal carcinoma: a meta-analysis of randomized clinical trials. Asian Pac J Cancer Prev, 13, 103-10.
40. Xu XL, Ling ZQ, Chen SZ, et al (2014). The impact of E-cadherin expression on the prognosis of esophageal cancer: a meta-analysis. Dis Esophagus, 27, 79-86.
41. Yagi T, Takeichi M (2000). Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. Genes Dev, 14, 1169-80.
42. Yu XW, Xu Q, Xu Y, et al (2014). Expression of the E-cadherin/β-catenin/tcf-4 pathway in gastric diseases with relation to Helicobacter pylori infection: clinical and pathological implications. Asian Pac J Cancer Prev, 15, 215-20.
43. Zhang QW, Liu L, Chen R, et al (2012). Matrix metalloproteinase-9 as a prognostic factor in gastric cancer: a meta-analysis. Asian Pac J Cancer Prev, 13, 2903-8.
44. Zhao XJ, Li H, Chen H, et al (2003). Expression of e-cadherin and beta-catenin in human esophageal squamous cell carcinoma: relationships with prognosis. World J Gastroenterol, 9, 225-32.